ST. LOUIS, Sept. 17, 2015 /PRNewswire/
-- Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading
Life Science and Technology Company, announced today it has signed
an exclusive global distribution agreement with IROA Technologies,
LLC to distribute IROA's Mass Spectrometry Metabolite Library of
Standards™ (MSMLS). The agreement partners IROA's MSMLS product
portfolio and software with the industry-leading eCommerce and
supply chain capabilities of Sigma-Aldrich.
MSMLS is a collection of high-quality small molecules that
span a broad range of primary metabolism. These are high purity
(>95%) compounds supplied in an economical, ready-to-use format.
The library of standards is most commonly used to provide retention
times and spectra for key metabolic compounds, help optimize mass
spectrometry analytical protocols and qualify and quantify mass
spectrometry sensitivity and limit of detection.
Under the agreement, Sigma-Aldrich has worldwide rights to sell
IROA Technologies' Mass Spectrometry Metabolite Library of
Standards. Sigma-Aldrich will
employ its sales, marketing and eCommerce expertise and leverage
the strength of its relationships with the scientific community to
present and distribute MSMLS and the corresponding software,
MSMLSDiscovery™.
"Our partnership with IROA, an award-winning innovative leader
in the field of metabolomics, reflects Sigma-Aldrich's commitment
to meet customer needs by supplying the most cutting-edge and
efficient technologies and our mission to enable science to improve
the quality of life," said Josef
Zihlmann, Vice President of Product Management and
R&D.
To learn more about Sigma-Aldrich's distribution of the Mass
Spectrometry Metabolite Library of Standards, visit
www.sigma-aldrich.com/msmls.
Cautionary Statement: The foregoing release contains
forward-looking statements that can be identified by terminology
such as "is expected" or similar expressions, or by expressed or
implied discussions regarding potential future revenues from
products derived there from. You should not place undue reliance on
these statements. Such forward-looking statements reflect the
current views of management regarding future events, and involve
known and unknown risks, uncertainties and other factors that may
cause actual results to be materially different from any future
results, performance or achievements expressed or implied by such
statements. There can be no guarantee that this or any other
product offering will assist the Company to achieve any particular
levels of revenue in the future. In particular, management's
expectations regarding this product offering could be affected by,
among other things, the Company's ability to obtain or maintain
patent or other proprietary intellectual property protection;
competition in general; government, industry and general public
pricing pressures; the impact that the foregoing factors could have
on the values attributed to the Company's assets and liabilities as
recorded in its consolidated balance sheet, and other risks and
factors referred to in Sigma-Aldrich's current Form 10-K on file
with the US Securities and Exchange Commission. Should one or more
of these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated, believed, estimated or expected.
Sigma-Aldrich is providing the
information in this press release as of this date and does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.
About Sigma-Aldrich: Sigma-Aldrich, a leading
Life Science and Technology company focused on enhancing human
health and safety, manufactures and distributes 250,000 chemicals,
biochemicals and other essential products to more than 1.4 million
customers globally in research and applied labs as well as in
industrial and commercial markets. With three distinct business
units - Research, Applied and SAFC Commercial - Sigma-Aldrich is
committed to enabling science to improve the quality of life. The
Company operates in 37 countries, has approximately 9,700 employees
worldwide and had sales of $2.79
billion in 2014.
For more information about Sigma-Aldrich, please visit its
website at www.sigma-aldrich.com.
Sigma-Aldrich and Sigma are
trademarks of Sigma-Aldrich Co., LLC registered in the US and other
countries. MSMLS and MSMLSDiscovery are trademarks of IROA
Technologies, LLC.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sigma-aldrich-announces-exclusive-distribution-agreement-with-iroa-technologies-llc-300144544.html
SOURCE Sigma-Aldrich